Topical treatments in atopic dermatitis: unexpectedly low use of emollients; use of topical corticosteroid is higher in juvenile patients, higher in male vs females, and shows independent associations with asthma and depression.

Conclusions Deficient use of emollients may be a factor contributing to AD severity. TCS use does not exceed current guidelines. Accurate quantification of topical treatments provides a widely accessible strategy to measure real-world impact of novel AD treatments. This article is protected by copyright. All rights reserved.
PMID: 31257575 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - June 29, 2019 Category: Dermatology Authors: Choi JY, Dawe R, Ibbotson S, Fleming C, Doney A, Foerster J Tags: Br J Dermatol Source Type: research